Quality of life for non-small cell lung cancer with target therapy

Chinese Journal of Lung Cancer

Volumn 12, Issue 6, 2009, Pages 615-616

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB;

CANCER PAIN; CLINICAL ASSESSMENT; CONFERENCE PAPER; CONTROLLED STUDY; COUGHING; DOSE TIME EFFECT RELATION; DYSPNEA; GENERAL CONDITION DETERIORATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PROTEIN TARGETING; QUESTIONNAIRE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 67650523277     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Andrea Bezjak, Dongsheng Tu, Lesley Seymour, et al. Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol, 24: 3831-3837.